Covid orphans: The young survivors indiatoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatoday.in Daily Mail and Mail on Sunday newspapers.
University Hospitals first in Ohio to treat patients with two FDA approved CAR T cancer therapies
Latest immunotherapies target multiple myeloma and diffuse large B-cell lymphoma
News provided by
Share this article
Share this article
CLEVELAND, May 6, 2021 /PRNewswire/ Oncologists at University Hospitals (UH) have two new powerful tools in the fight against cancer following the announcement that Abecma & Breyanzi, from Bristol Myers Squibb (BMS), are currently being used to treat patients at UH Seidman Cancer Center. Providing these latest CAR T-cell therapies to our patients is just another way UH Seidman Cancer Center is leading the way in immunotherapy, says Ted Teknos, MD, President and Chief Scientific Director of UH Seidman. Last fall, the Wesley Center for Immunotherapy at UH Seidman was named in honor of Kimberly and Joseph Wesley. The Wesley Family donated $10 million to support groundbreaking research to bring new, life-extending immunotherapy treatments to pa
and last updated 2021-04-07 18:57:48-04
TALLAHASSEE, Fla â Anger and irritation are boiling over for many when it comes to unemployment benefits.
âYouâve had a year, a year get it together. I mean come on,â said Joseph Wesley, who says his account was on an incarceration hold even though he hasnât been in jail for years.
The DEO admits itâs an issue that has wrongfully impacted hundreds of thousands of accounts and officials say theyâre trying hard to fix it.
But, Wesleyâs troubles go further than that â he was instructed by the DEO to reverify his identity and was officially verified on March 30 by ID.Me, a company hired by the DEO to weed out fraud.
Hattiesburg candidates forum set for Tuesday night wdam.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wdam.com Daily Mail and Mail on Sunday newspapers.